Tempest Therapeutics (TPST) Other Operating Expenses (2015 - 2018)

Tempest Therapeutics has disclosed Other Operating Expenses across 4 years of filings, most recently posting -$1.9 million for Q3 2018.

• In Q3 2018, Other Operating Expenses fell 18960.0% year-over-year to -$1.9 million; the TTM figure through Jun 2019 stood at -$1.9 million (down 106.7% YoY), while the FY2017 annual figure was $26.4 million, up 388.59% from the prior year.
• Other Operating Expenses came in at -$1.9 million for Q3 2018 at Tempest Therapeutics, down from $99000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $25.8 million in Q4 2017 to a low of -$1.9 million in Q3 2018.
• Average Other Operating Expenses over 4 years is $2.3 million, with a median of $940000.0 recorded in 2015.
• Year-over-year, Other Operating Expenses soared 3260.0% in 2016 and sank 18960.0% in 2018.
• Over 4 years, Other Operating Expenses stood at $1.2 million in 2015, then advanced by 23.75% to $1.4 million in 2016, then surged by 1701.61% to $25.8 million in 2017, then slumped by 107.38% to -$1.9 million in 2018.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$1.9 million in Q3 2018, $99000.0 in Q2 2018, and $2.6 million in Q1 2018.